COVID 及与 COVID 疫苗相关的角膜发病机制：综述。
COVID and COVID vaccine-related corneal morbidity: A review.
机构信息
Dr. R. P. Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
出版信息
Indian J Ophthalmol. 2023 Dec 1;71(12):3595-3599. doi: 10.4103/IJO.IJO_765_23. Epub 2023 Nov 20.
Abstract
Systemic coronavirus disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has had several ocular consequences. Many vaccines have been developed against the disease, with adverse events being reported as well. Various ocular adverse events secondary to coronavirus disease 2019 (COVID-19) vaccines have also featured in literature in recent times. This review features the reported corneal-related effects of COVID infection and vaccination. These include direct effects on corneal grafts and unilateral or bilateral corneal melts. The compilation of reported experiences from across the world in this systematic review will help clinicians recognize the possible presentations, pathogenesis, and management of the same.
摘要
由严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 病毒引起的全身性冠状病毒病已经导致了多种眼部后果。目前已经开发出许多针对该疾病的疫苗，同时也报告了一些不良反应。最近的文献中还报道了与 2019 年冠状病毒病 (COVID-19) 疫苗相关的各种眼部不良反应。本综述介绍了 COVID 感染和疫苗接种引起的已报道的角膜相关影响。这些影响包括对角膜移植物的直接影响以及单侧或双侧角膜溶解。本系统综述中对全球报告经验的汇编将帮助临床医生识别可能的表现、发病机制和处理方法。
相似文献
1
COVID and COVID vaccine-related corneal morbidity: A review.COVID 及与 COVID 疫苗相关的角膜发病机制：综述。
Indian J Ophthalmol. 2023 Dec 1;71(12):3595-3599. doi: 10.4103/IJO.IJO_765_23. Epub 2023 Nov 20.
2
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗（灭活，Vero 细胞）有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
3
Adverse Cardiovascular Effects of COVID-19 Vaccination: A Systematic Review.COVID-19 疫苗接种的心血管不良影响：系统评价。
Cardiol Rev. 2024;32(4):314-319. doi: 10.1097/CRD.0000000000000508. Epub 2024 Jun 6.
4
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET).澳大利亚癌症成人和儿童中 SARS-CoV-2 疫苗后监测研究方案：一项关于 SARS-CoV-2 疫苗接种的安全性以及血清学和免疫学反应的观察性研究（SerOzNET）。
BMC Infect Dis. 2022 Jan 20;22(1):70. doi: 10.1186/s12879-021-07019-1.
5
Nephrotic syndrome following COVID-19 vaccination: a systematic review.接种 COVID-19 疫苗后的肾病综合征：系统评价。
J Nephrol. 2023 Dec;36(9):2431-2440. doi: 10.1007/s40620-023-01710-z. Epub 2023 Jul 28.
6
Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety Network.在加拿大国家疫苗安全网络中，有既往严重急性呼吸综合征冠状病毒 2 感染史的个体接种 mRNA 和病毒载体疫苗后的不良反应。
Clin Infect Dis. 2023 Mar 21;76(6):1088-1102. doi: 10.1093/cid/ciac852.
7
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks.主要的严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗相关不良反应；益处大于风险。
Expert Rev Vaccines. 2022 Oct;21(10):1377-1394. doi: 10.1080/14760584.2022.2116008. Epub 2022 Aug 24.
8
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
9
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19（Sars-Cov-2）的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
10
SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review.SARS-CoV-2 相关及新冠病毒疫苗诱导的血栓栓塞事件：比较综述。
Rev Med Virol. 2022 Jul;32(4):e2327. doi: 10.1002/rmv.2327. Epub 2022 Feb 3.
引用本文的文献
1
Optical quality changes of the eye during peak SARS-CoV-2 pandemic in young adults.年轻成年人在新冠疫情高峰期眼部光学质量的变化
Heliyon. 2024 Oct 17;10(23):e39497. doi: 10.1016/j.heliyon.2024.e39497. eCollection 2024 Dec 15.
2
Conditional reprogrammed human limbal epithelial cell model for anti-SARS-CoV-2 drug screening.用于抗SARS-CoV-2药物筛选的条件重编程人角膜缘上皮细胞模型
Heliyon. 2024 Apr 23;10(9):e30044. doi: 10.1016/j.heliyon.2024.e30044. eCollection 2024 May 15.
本文引用的文献
1
A case of acute endothelial corneal transplant rejection following immunization with ChAdOx1 nCoV-19 coronavirus vaccine.接种 ChAdOx1 nCoV-19 冠状病毒疫苗后发生急性内皮角膜移植排斥反应 1 例。
Indian J Ophthalmol. 2022 May;70(5):1817-1818. doi: 10.4103/ijo.IJO_66_22.
2
Acute Bilateral Descemet Membrane Endothelial Keratoplasty Graft Rejection After the BNT162b2 mRNA COVID-19 Vaccine.BNT162b2 mRNA新冠疫苗接种后发生急性双侧Descemet膜内皮角膜移植排斥反应
Int Med Case Rep J. 2022 Apr 14;15:201-204. doi: 10.2147/IMCRJ.S362698. eCollection 2022.
3
Five Cases of Corneal Graft Rejection After Recent COVID-19 Vaccinations and a Review of the Literature.五例近期接种 COVID-19 疫苗后发生的角膜移植排斥反应病例及文献复习。
Cornea. 2022 May 1;41(5):669-672. doi: 10.1097/ICO.0000000000002980.
4
Covid-19 vaccination and possible link to Herpes zoster.新冠病毒疫苗接种与带状疱疹的可能关联。
Am J Ophthalmol Case Rep. 2022 Mar;25:101359. doi: 10.1016/j.ajoc.2022.101359. Epub 2022 Jan 26.
5
Presumed DMEK Graft Rejection Associated With COVID-19 Infection.与新冠病毒感染相关的疑似 Descemet 膜内皮角膜移植排斥反应
Cornea. 2022 Feb 1;41(2):e1. doi: 10.1097/ICO.0000000000002882.
6
Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic Review.接种新冠疫苗后的眼部表现：一项系统评价
Vaccines (Basel). 2021 Nov 27;9(12):1404. doi: 10.3390/vaccines9121404.
7
Stromal rejection in penetrating keratoplasty following COVID-19 vector vaccine (Covishield) - A case report and review of literature.COVID-19 载体疫苗（Covishield）后穿透性角膜移植中的基质排斥反应 - 病例报告和文献复习。
Indian J Ophthalmol. 2022 Jan;70(1):319-321. doi: 10.4103/ijo.IJO_2539_21.
8
Corneal Graft Rejection After Inactivated SARS-CoV-2 Vaccine: Case Report.灭活 SARS-CoV-2 疫苗接种后角膜移植排斥反应：病例报告。
Cornea. 2022 Apr 1;41(4):502-504. doi: 10.1097/ICO.0000000000002970.
9
Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns.新冠病毒疾病mRNA疫苗（BNT162b2）接种后随访前六个月内发生的双角膜移植排斥反应：病例报告、现状与伦理考量
Vaccines (Basel). 2021 Nov 3;9(11):1274. doi: 10.3390/vaccines9111274.
10
Acute graft rejection in a high-risk corneal transplant following COVID-19 vaccination: A case report.新冠病毒疫苗接种后高危角膜移植中发生急性移植物排斥反应：病例报告。
Indian J Ophthalmol. 2021 Dec;69(12):3757-3758. doi: 10.4103/ijo.IJO_2515_21.
Zotero 插件